<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-04-22 23:39:46Pharmaceutical sciences Immunosuppressants Monoclonal antibodies Ustekinumab Infliximab Golimumab Clinical trial Biologic Medical prescription Centocor Pharmacology Medicine |
 | Ixekizumab for moderate to severe chronic plaque psoriasisDocID: 1gyoS - View Document |
 | 438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL-DocID: 1fNC6 - View Document |
 | Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or RequirementDocID: 1a6Du - View Document |
 | Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixiDocID: 1a5mb - View Document |
 | Microsoft Word - 106937148_19DocID: 19ODp - View Document |